Drugs to Watch 2020
Market intelligence reports
BioWorld - Monday, March 30, 2020
» Phase I clinical trials: February 2020
Looking to read the full article? Subscribe to BioWorld.
Phase I clinical trials: February 2020
March 13, 2020
Therapeutic area data reported by biopharma companies on phase I trials in February 2020, including: Abeona, Actinium, Advaxis, Agenus, Apeiron, Aravive, Arrowhead, Aura, BMS, Celltrion, Ciclomed, Compugen, Corvus, Cyclo, Cytodyn, Cytomx, Exelixis, Faron, Freeline, Genetx, Genprex, Harbour, Immix, Incysus, Inflazome, Innovation, Ionctura, Iteos, Kodiak Sciences, Matinas, Mirati, Moderna, Moleculin, Neurimmune, Noxopharm, Ocular, Oxurion, Pandion, Phasebio, Regulus, Reneo, Restorbio, Sernova, Soricimed, Sorrento, Takeda, Transgene, Urovant.
Analysis and data insight
Already a subscriber?